Sort
16,300 grants matching “fatty liver disease”
The role of SRSF1 in liver function and NASH
$50,520Waqar Arif · University Of Illinois At Urbana-Champaign · F30 · FY2020 · DK
Investigating Mechanisms of Acetyl-CoA Sensing and Its Implications in Non-Alcoholic Fatty Liver Disease
$50,520Joyce Ying Liu · University Of Pennsylvania · F30 · FY2020 · DK
Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic Tumorigenesis
$50,520Hanna Erickson · University Of Illinois At Urbana-Champaign · F30 · FY2020 · CA
Regulation of metabolic stress by the Snhg3 locus.
$50,520Arthur Curtis Sletten · Washington University · F30 · FY2020 · DK
Kansas Center for Metabolism and Obesity REsearch (KC-MORE)
$50,500Steven A Weinman · University Of Kansas Medical Center · P20 · FY2023 · GM
ETHANOL REGULATION OF ADIPONECTIN AND ITS SIGNALING
$50,482Min You · University Of South Florida · R01 · FY2013 · AA
Metabolic Characterization of the Novel Adipokine CTRP3
$50,474Jonathan M Peterson · Johns Hopkins University · F32 · FY2010 · DK
The Essentiality of Arachidonic Acid (AA), Docosahexaenoic Acid (DHA)
$50,474Erica M Fallon · Boston Children'S Hospital · F32 · FY2010 · DK
Altered Lipid Droplet Trafficking: Role in Alcoholic Fatty Liver Disease
$50,374Carol A Casey · University Of Nebraska Medical Center · R01 · FY2015 · AA
Characterizing the Impact of Gestational Diabetes on Immunity and Group B Streptococcal Virulence in the Maternal Reproductive Tract
$50,194Vicki Mercado · Baylor College Of Medicine · F31 · FY2023 · AI
PERIOD Protein Complexes of the Mammalian Circadian Clock
$50,130Andrew Scott Delemos · Massachusetts General Hospital · F32 · FY2011 · DK
FFA Metabolism, Insulin Resistance and Type 2 Diabetes
$50,116University Of Texas Hlth Sci Ctr San Ant · F32 · FY2002 · DK
Regulation of oxidative stress signaling by tyrosine phosphorylation of antioxidant enzymes
$50,069Tigist Y Tamir · Massachusetts Institute Of Technology · K99 · FY2024 · GM
A Genetic Model for Understanding the Metabolic Syndrome/Obesity Relationship
$50,054Benjamin Jennings Renquist · Vanderbilt University · F32 · FY2009 · DK
The role of hypothalamic PPARg in diet-induced obesity
$50,054Karen Ryan · University Of Cincinnati · F32 · FY2009 · DK
Mechanisms for the Effects of Hypothalamic PTP1B on Energy Balance
$50,054Karyn Joanne Catalano · Beth Israel Deaconess Medical Center · F32 · FY2009 · DK
Investigating the Effects of Adipocyte-Specific Knockout of Tribbles1 on Plasma Adiponectin Levels and Lipoprotein Metabolism
$50,016Elizabeth Eun-Jun Ha · Columbia University Health Sciences · F30 · FY2019 · HL
Coordinated suppression of hepatic steatosis via targeting of FLCN
$50,016Bridget Gosis · University Of Pennsylvania · F30 · FY2019 · DK
Investigating the Relationship Between Racial Residential Segregation and Hepatocellular Carcinoma
$50,016Amin Bemanian · Medical College Of Wisconsin · F30 · FY2019 · CA
Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic Tumorigenesis
$50,016Hanna Erickson · University Of Illinois At Urbana-Champaign · F30 · FY2019 · CA
The role of SRSF1 in liver function and NASH
$50,016Waqar Arif · University Of Illinois At Urbana-Champaign · F30 · FY2019 · DK
Transcriptional Regulation of Macrophage Function by LXR in Atherosclerosis
$50,016David G Thomas · Columbia University Health Sciences · F30 · FY2019 · HL
I-Corps: Self-assembling, protein-based contrast agent targeted to collagen Type 1
$50,000Jin K Montclare · New York University · · FY2022 · TIP
I-Corps: Polymer-based drug delivery system
$50,000Meng Deng · Purdue University · · FY2016 · TIP
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease
$50,000Rolf F Kletzien · Metabolic Solutions Development Co · R42 · FY2012 · AA